sLORETA neurofeedback in fibromyalgia

Authors

  • Ruben Pérez-Elvira Psychophysiology Lab (NEPSA Rehabilitación Neurológica), Salamanca, Spain.
  • Ana Jiménez Gómez Psychophysiology Lab (NEPSA Rehabilitación Neurológica), Salamanca, Spain.

DOI:

https://doi.org/10.31117/neuroscirn.v3i1.40

Keywords:

Fibromyalgia, sLORETA neurofeedback, neurofeedback

Abstract

Fibromyalgia is a chronic and incapacitating condition that produces, as main symptoms, pain, and stiffness. In addition to these physical symptoms, it is also accompanied by psychological symptoms such as cognitive deficits, anxiety, and depression. One of the non-pharmacological treatments that have been used in this pathology in recent years is neurofeedback. In this study, we analyze the efficacy of sLORETA Neurofeedback in the case of fibromyalgia. The experimental subject was a 37-year-old patient. Quantified electroencephalography studies were applied on three occasions, one initial, another after fifteen days of waiting list, and another after treatment. Psychometric scales were also applied at the same time to evaluate the patient's psychological and physical state. The treatment consisted of 5 sessions of Neurofeedback LORETA in Brodmann area 2. After the treatment, a neurometric, psychometric, and clinical improvement were found. The improvement of the patient after 5 sessions is relevant since previous studies using neurofeedback in fibromyalgia, despite finding positive results, needed a higher number of sessions to achieve relevant results. Therefore, the intervention with neurofeedback LORETA in fibromyalgia patients could be an alternative or complement to current treatments.

References

Alanoğlu, E., Ulaş, U. H., Özdağ, F., Odabaşı, Z., Çakçı, A., & Vural, O. (2005). Auditory event-related brain potentials in fibromyalgia syndrome. Rheumatology International, 25(5), 345–349. https://doi.org/10.1007/s00296-004-0443-3

Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897. https://doi.org/10.1037/0022-006X.56.6.893

Beck, A. T., Steer, R. A., & Brown, G. K. (1996). BDI-II, Beck Depression Inventory: Manual. Psychological Corporation.

Bedny, M., Aguirre, G. K., & Thompson-Schill, S. L. (2007). Item analysis in functional magnetic resonance imaging. NeuroImage, 35(3), 1093–1102. https://doi.org/10.1016/j.neuroimage.2007.01.039

Carrobles, J. A. (2016). Bio/neurofeedback. Clínica y Salud, 27(3), 125–131. https://doi.org/10.1016/j.clysa.2016.09.003

Casullo, M. M. (2004). EL INVENTARIO DE SÍNTOMAS SCL-90-R de L. 8. https://www.fundacionforo.com/pdfs/inventariodesintomas.pdf

Chen, Y., Liu, H.-C., Jin, Z., Liu, G., & Zhang, Q.-S. (2006). Functional activity mapping during anticipation of dental pain. West China Journal of Stomatology, 24(2), 121–124.

Collura, T. (2012). BrainAvatar: Integrated Brain Imaging, Neurofeedback, and Reference Database System. NeuroConnections, Summer, 31–36.

Collura, T. (2014). Technical foundations of neurofeedback. Routledge, Taylor & Francis Group.

Collura, T. F. (2017). Quantitative EEG and Live Z-Score Neurofeedback—Current Clinical and Scientific Context. Biofeedback, 45(2), 25–29. https://doi.org/10.5298/1081-5937-45.1.07

Derogatis, L. R., & Unger, R. (2010). Symptom Checklist-90-Revised. In I. B. Weiner & W. E. Craighead (Eds.), The Corsini Encyclopedia of Psychology. John Wiley & Sons, Inc. https://doi.org/10.1002/9780470479216.corpsy0970

Donaldson, C. C. S., Sella, G. E., & Mueller, H. H. (1998). Fibromyalgia: A retrospective study of 252 consecutive referrals. Canadian Journal of Clinical Medicine, 5(6), 116–127.

Fisher, W., Piazza, C. C., Bowman, L. G., Hagopian, L. P., Owens, J. C., & Slevin, I. (1992). A comparison of two approaches for identifying reinforcers for persons with severe and profound disabilities. Journal of Applied Behavior Analysis, 25(2), 491–498. https://doi.org/10.1901/jaba.1992.25-491

Gracefire, P. (2016). Introduction to the Concepts and Clinical Applications of Multivariate Live Z-Score Training, PZOK and sLORETA FEEDBACK. In T. Collura & J. A. Frederick (Eds.), Handbook of Clinical QEEG and Neurofeedback (pp. 326–383). Routledge.

Hammer, B. U., Colbert, A. P., Brown, K. A., & Ilioi, E. C. (2011). Neurofeedback for Insomnia: A Pilot Study of Z-Score SMR and Individualized Protocols. Applied Psychophysiology and Biofeedback, 36(4), 251–264. https://doi.org/10.1007/s10484-011-9165-y

Howe, R. C., & Sterman, M. B. (1972). Cortical-subcortical EEG correlates of suppressed motor behavior during sleep and waking in the cat. Electroencephalography and Clinical Neurophysiology, 32(6), 681–695. https://doi.org/10.1016/0013-4694(72)90104-6

INFOCOP: Consejo General de la Psicología de España. (2006). ¿QUÉ MIDE REALMENTE EL SCL-90-R? http://www.infocop.es/view_article.asp?id=673#inicio

Kanda, M., Nagamine, T., Ikeda, A., Ohara, S., Kunieda, T., Fujiwara, N., Yazawa, S., Sawamoto, N., Matsumoto, R., Taki, W., & Shibasaki, H. (2000). Primary somatosensory cortex is actively involved in pain processing in human. Brain Research, 853(2), 282–289. https://doi.org/10.1016/S0006-8993(99)02274-X

Kayiran, S., Dursun, E., Ermutlu, N., Dursun, N., & Karamürsel, S. (2007). Neurofeedback in fibromyalgia syndrome. The Journal of the Turkish Society of Algology, 19(3), 47–53.

Kayıran, S., Dursun, E., Dursun, N., Ermutlu, N., & Karamürsel, S. (2010). Neurofeedback Intervention in Fibromyalgia Syndrome; a Randomized, Controlled, Rater Blind Clinical Trial. Applied Psychophysiology and Biofeedback, 35(4), 293–302. https://doi.org/10.1007/s10484-010-9135-9

Kim, J., Loggia, M. L., Cahalan, C. M., Harris, R. E., Beissner, F., Garcia, R. G., Kim, H., Barbieri, R., Wasan, A. D., Edwards, R. R., & Napadow, V. (2015). The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction. Arthritis & Rheumatology, 67(5), 1395–1405. https://doi.org/10.1002/art.39043

Michel, C. M., & Brunet, D. (2019). EEG sourceimaging: a practical review of the analysis steps. Frontiers in Neurology, 10, 325. https://doi.org/10.3389/fneur.2019.00325

Minhoto, G., Roizenblatt, S., & Tufik, S. (1997). The effect of biofeedback in fibromyalgia. Sleep Research, 26, 573.

Mueller, H. H., Donaldson, C. C., Nelson, D. V., & Layman, M. (2001). Treatment of fibromyalgia incorporating EEG-Driven stimulation: A clinical outcomes study. Journal of Clinical Psychology, 57(7), 933–952.

National Fibromyalgia Association. (2018). Treatment. National Fibromyalgia Association (NFA). http://www.fmaware.org/about-fibromyalgia/treatment/

NIH: Instituto Nacional de Artritis y Enfermedades Musculoesqueléticas y de la Piel. (2018). Fibromialgia. https://www.niams.nih.gov/es/informacion-de-salud/fibromialgia

Ozgocmen, S., Yoldas, T., Kamanli, A., Yildizhan, H., Yigiter, R., & Ardicoglu, O. (2003). Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia. Annals of the Rheumatic Diseases, 62(6), 551–555. https://doi.org/10.1136/ard.62.6.551

Sanz, J. (2019, January 26). Proyecto de Apoyo a la Evaluación Psicológica Clínica. https://docplayer.es/40905786-Autores-aaron-t-beck-norman-epstein-gary-brown-y-robert-a-steer.html

Schwartz, M. S. (1995). Biofeedback: A practitioner’s guide. In Fibromyalgia syndrome (M. S. Schwartz, pp. 803–819). Guilford Press.

Smith, M. L. (2017). sLORETA in clinical practice: not all ROIs are created equal. In T. F. Collura & J. A. Frederick (Eds.), Handbook of clinical QEEG and neurotherapy (pp. 283–299). Routledge, Taylor & Francis Group.

Soutar, R. G., & Longo, R. E. (2011). Doing neurofeedback: An introduction. ISNR Research Foundation.

Published

2020-01-30

How to Cite

Pérez-Elvira, R. and Jiménez Gómez, A. (2020) “sLORETA neurofeedback in fibromyalgia”, Neuroscience Research Notes, 3(1), pp. 1-10. doi: 10.31117/neuroscirn.v3i1.40.

Issue

Section

Case Notes